4//SEC Filing
Prentiss Christopher B 4
Accession 0001209191-20-056424
CIK 0001328143other
Filed
Nov 1, 7:00 PM ET
Accepted
Nov 2, 4:44 PM ET
Size
5.3 KB
Accession
0001209191-20-056424
Insider Transaction Report
Form 4
Prentiss Christopher B
Chief Accounting Officer
Transactions
- Sale
Common Stock
2020-11-02$3.21/sh−2,050$6,581→ 78,890 total
Footnotes (2)
- [F1]Pursuant to the mandatory sale to cover withholding tax requirements of the issuer's equity incentive plan, the shares were sold to cover the tax obligation realized upon the vesting of restricted stock units.
- [F2]The shares were sold at prices ranging from $3.16 to $3.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeother
Related Parties
1- filerCIK 0001717583
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 7:00 PM ET
- Accepted
- Nov 2, 4:44 PM ET
- Size
- 5.3 KB